Science Explorer Interactive view Map
Company · San Diego · United States

Amplyx Pharmaceuticals (United States)

amplyx.comROR OpenAlex
World rank, all time
#17,605
of 42,892
Rank in United States
#3,820
of 8,685
Research works
180
▲ 27% vs 2013–17
Citations
15k
84.9 per fractional work
Top-10% rate
37.7%
record average 16.5%
Open access
37%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Biochemistry, Genetics and Molecular Biology: 4.77× its world share, 2 worksBiochemistry, Geneti…Neuroscience: 2.82× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 10.65× its world share, 0 worksPharmacology, Toxico…Engineering: 0.35× its world share, 0 worksEngineeringMaterials Science: 0.51× its world share, 0 worksMaterials SciencePhysics and Astronomy: 1.13× its world share, 0 worksPhysics and AstronomyMedicine: 2.75× its world share, 5 worksMedicineEconomics, Econometrics and Finance: 1.75× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 10.7×. Every wedge is a field page.

Which keywords describe research at Amplyx Pharmaceuticals (United States)?

By fractional works in all years, weighted toward what it does more of than the world: Glycemic Control, Insulin Therapy, Cancer Therapy, Type 2 Diabetes, Heart Failure, Obesity, Cardiovascular Outcomes and Glucose Control.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Glycemic Control20▲ 81×4 topics
  2. Insulin Therapy20▲ 98×3 topics
  3. Cancer Therapy17▲ 15×12 topics
  4. Type 2 Diabetes15▲ 46×4 topics
  5. Oxidative Stress15▲ 4.5×11 topics
  6. Heart Failure14▲ 17×6 topics
  7. Obesity14▲ 9.9×11 topics
  8. Cardiovascular Outcomes13▲ 173×1 topic
  9. Glucose Control13▲ 173×1 topic
  10. Inflammation12▲ 2.9×27 topics
  11. Cardiovascular Disease12▲ 6.0×11 topics
  12. Diabetes Mellitus11▲ 28×2 topics
  13. Pancreatic Islets11▲ 92×1 topic
  14. ß-Cell Dysfunction11▲ 92×1 topic
  15. Diabetes10▲ 11×9 topics
  16. Stress10▲ 14×3 topics
  17. Insulin Resistance10▲ 12×8 topics
  18. Transcriptional Regulation10▲ 22×6 topics
  19. Cancer9▲ 3.7×17 topics
  20. Antifungal Therapy9▲ 52×3 topics
  21. Oncogenic Mutations8▲ 99×2 topics
  22. Depression8▲ 5.9×3 topics
  23. Anxiety8▲ 12×2 topics
  24. Neuropeptides8▲ 41×2 topics
  25. Signal Transduction8▲ 17×4 topics
  26. Cell Migration8▲ 50×2 topics
  27. Immune Modulation8▲ 30×2 topics
  28. Opioid7▲ 66×1 topic
  29. Receptors7▲ 66×1 topic
  30. Type 1 Diabetes7▲ 42×2 topics
  31. Calcium Signaling7▲ 28×3 topics
  32. Cancer Risk7▲ 14×3 topics
  33. Tumor Suppression7▲ 32×2 topics
  34. Protein Kinases6▲ 129×1 topic
  35. Ras Signaling6▲ 129×1 topic
  36. Ghrelin6▲ 102×1 topic
  37. Leptin6▲ 102×1 topic
  38. Cell Signaling6▲ 10×5 topics
  39. Continuous Glucose Monitoring6▲ 75×1 topic
  40. Hypoglycemia6▲ 75×1 topic

Which research topics does Amplyx Pharmaceuticals (United States) publish most on?

By volume in 2022–2025: Amyotrophic Lateral Sclerosis Research, Antifungal resistance and susceptibility, Antibiotic Resistance in Bacteria and Burkholderia infections and melioidosis.

Amyotrophic Lateral Scle…1Amyotrophic Lateral Sclerosis Research: 1 fractional worksAntifungal resistance and susceptibility: 0 fractional worksAntibiotic Resistance in Bacteria: 0 fractional worksBurkholderia infections and melioidosis: 0 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 0 fractional worksBacterial Identification and Susceptibility Testing: 0 fractional worksMolecular Biology Techni…0Molecular Biology Techniques and Applications: 0 fractional worksMycobacterium research and diagnosis: 0 fractional worksGenetic Neurodegenerative Diseases: 0 fractional worksPolyomavirus and related diseases: 0 fractional works
NeurologyInfectious DiseasesMolecular MedicineEpidemiology5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Amyotrophic Lateral Sclerosis Research Neurology 1 works
  2. 2 Antifungal resistance and susceptibility Infectious Diseases 0 works
  3. 3 Antibiotic Resistance in Bacteria Molecular Medicine 0 works
  4. 4 Burkholderia infections and melioidosis Epidemiology 0 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 0 works
  6. 6 Bacterial Identification and Susceptibility Testing Clinical Biochemistry 0 works
  7. 7 Molecular Biology Techniques and Applications Molecular Biology 0 works
  8. 8 Mycobacterium research and diagnosis Epidemiology 0 works
  9. 9 Genetic Neurodegenerative Diseases Cellular and Molecular Neuroscience 0 works
  10. 10 Polyomavirus and related diseases Oncology 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available36.9%not open63.1%

World: 28% of research is openly available.

with international co-authors5.6%domestic only94.4%

World: 19% is written across borders.

How has Amplyx Pharmaceuticals (United States)'s research output changed?

Output in 2018–2022 was 27% higher than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in San Diego

All research institutions in San Diego

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.